Loading ABT...
Abbott LaboratoriesABTAs of 31 July 2026
−13
PositiveNegative
Equilibrium
Valuation
Is Abbott Laboratories undervalued or overvalued?
Where Abbott Laboratories (ABT) trades across 21 valuation metrics, from price-to-sales and forward P/E to book and cash-flow multiples, each ranked against its own five-year history rather than a broad sector average, so you can see whether it is genuinely cheap or expensive on its own terms. Information, not advice.
Abbott LaboratoriesABTLast 5 years
V—E—F—A—
——
ABT priceasymmetryquant.com